A detailed history of Voya Investment Management LLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Voya Investment Management LLC holds 58,309 shares of LEGN stock, worth $1.91 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
58,309
Previous 19,885 193.23%
Holding current value
$1.91 Million
Previous $880,000 222.84%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$43.55 - $59.88 $1.67 Million - $2.3 Million
38,424 Added 193.23%
58,309 $2.84 Million
Q2 2024

Dec 03, 2024

SELL
$39.5 - $57.22 $1.52 Million - $2.2 Million
-38,424 Reduced 65.9%
19,885 $880,000
Q2 2024

Aug 14, 2024

SELL
$39.5 - $57.22 $67,940 - $98,418
-1,720 Reduced 7.96%
19,885 $880,000
Q1 2024

Dec 06, 2024

SELL
$55.06 - $69.99 $2.02 Million - $2.57 Million
-36,704 Reduced 62.95%
21,605 $1.21 Million
Q1 2024

May 15, 2024

SELL
$55.06 - $69.99 $1.52 Million - $1.93 Million
-27,538 Reduced 56.04%
21,605 $1.21 Million
Q4 2023

Feb 14, 2024

BUY
$57.25 - $69.74 $395,368 - $481,624
6,906 Added 16.35%
49,143 $2.96 Million
Q3 2023

Nov 14, 2023

SELL
$63.16 - $76.5 $32,527 - $39,397
-515 Reduced 1.2%
42,237 $2.84 Million
Q2 2023

Aug 14, 2023

BUY
$46.28 - $75.01 $1.7 Million - $2.75 Million
36,632 Added 598.56%
42,752 $2.95 Million
Q1 2023

May 15, 2023

BUY
$43.42 - $57.37 $47,675 - $62,992
1,098 Added 21.86%
6,120 $295,000
Q4 2022

Feb 14, 2023

BUY
$38.8 - $55.46 $194,853 - $278,520
5,022 New
5,022 $250,000
Q2 2022

Aug 15, 2022

BUY
$33.54 - $55.0 $160,388 - $263,010
4,782 New
4,782 $263,000
Q1 2022

May 16, 2022

SELL
$31.02 - $48.18 $145,700 - $226,301
-4,697 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$41.14 - $56.98 $193,234 - $267,635
4,697 New
4,697 $219,000

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $5.49B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.